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Mycotoxins, such as aflatoxins and ochratoxins are secondary metabolites produced by moulds. Ochratoxin A (OA) is produced by Aspergillus and Penicillium species growing on cereals and other plant substrates, and is frequently found as a contaminant in animal feed and in human food in temperate areas (1, 2) .
Humans are exposed to OA by consumption of food which has been directly contaminated through growth of fungi, and by food products derived from exposed animals. In addition, probably also by inhalation of spores containing mycotoxins (3, 4) . Spores from P. verrucosum, the major ochratoxin producer in crops in the colder climatic zones, were shown to contain both OA and citrinin (5) , another mycotoxin produced by this common mould. Inhalation of spores should consequently be an exposure route taken into consideration.
Seasonal fluctuations in OA levels in cereals are reflected by OA levels in humans and in animals (2) . In general the growth of mould, and the production of mycotoxins in the crop depend strongly on environmental conditions such as moisture and temperature, and is generally increased in wet summers.
OA has been shown to be nephrotoxic, carcinogenic, teratogenic and immunosuppressive (6) . Acute human intoxication by OA is unlikely to occur at the OA levels generally found in foodstuffs, but the long-term effects of continuous lowdose exposure to OA on human health could be significant. The major target organ of OA toxicity is the kidney. The toxin has been strongly suspected of being involved in endemic Balkan nephropathy, and of being associated with urinary tract tumours in humans (7).
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A high incidence of OA contamination of human blood in Europe and Canada suggests a continuous and widespread human exposure to this toxin, although at low levels. Analyses of blood samples from different European countries show OA contamination at concentrations from 100 to 14 400 ng/l (8) . The concentration level of OA in human milk is reported to be roughly  1/10 that in human blood (9) . Different risk assessments of the intake of OA have been performed, and different tolerable daily intakes (TDIs) have been suggested (6, 10, 11) . The Nordic Working Group on Food Toxicology and Risk Evaluation has suggested a maximum TDI of OA in humans of 5 ng per kg body weight, based on carcinogenicity studies with OA in rats (12).
In human milk samples highest OA concentrations have been found in Sierra Leone, where thirty-five per cent of the samples contained OA at levels from 200 to 337 000 ng/l OA (detection limit: 200 ng/l) (13) . In Italy 20 % of milk samples had OA levels in the range of 100 to 12 000 ng/l (14) . Lower concentrations were found in samples from Germany (17-30 ng/l in 11% of the samples) (15) and Switzerland (5-14 ng/kg in 10% of the samples) (16) . In a Swedish study 23 of 40 (58 %) human milk samples contained OA (range 10-40 ng/l, detection limit 10 ng/l) (9).
Prenatal exposure to OA can occur by transplacental transfer (17) . It is reported that the OA concentration in fetal serum is twice the maternal one, indicating a possible active placental transport (16) . The health risk of OA to neonates and infants has not yet been evaluated.
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The purpose of the present work was to determine the occurrence of OA in human milk samples from different regions in Norway and to determine the level of infant exposure to OA from human milk.
Materials and methods

Reagents
OA was purchased from Sigma (St Louis, MO, USA). A solution of OA (10 g /ml in methanol) was calibrated spectrophotometrically at 333 nm using the value of 6640 for the extinction coefficient (18) . The OA solution was diluted to 10 -8 M in methanol and stored at -20 C.
Milk samples
Human milk samples were collected during May-August 1994. One hundred and fifteen milk samples were obtained from women living in three different climatic regions in Norway: Elverum (south-east inland, n=48), Trondheim (middle coast, n=19) and Bodø (north coast, n=48) ( The study was approved by the regional ethical committee, Norway.
Extraction and clean-up
The method described by Breitholtz-Emanuelsson et al (9) was used with slight modifications concerning the purification and HPLC-conditions and with another confirmation method for OA. A volume of 5 ml methanol, 0.5 ml 1 M HCl, and 5 ml chloroform were added to a 2 ml portion of milk. Instead of a self-packed silica gel 
Statistics
The standard curves used for quantitation were calculated by the least-squares method. The coefficient of variation of the peak height of OA at different injections of the same standard solution was 3 % (within-day variation). The coefficient of variation of the peak height of OA from spiked milk samples was 12 % (between days). Fisher's exact test was used to compare the OA levels in the three areas.
A p value less than 0.05, using a two tailed test, was considered to be statistically significant. 
Discussion
Supposed a 4-kg infant consumes 500 ml of milk per day the milk must contain less than 40 ng OA per l to prevent a daily intake exceeding the suggested TDI of 5 ng/kg bw. The present investigation demonstrates that in Norway 2 -26 % of the infants were exposed to milk contaminated with OA at levels that exceed the TDI.
Significant individual and regional differences in OA levels in the milk were found.
In the east and middle part of Norway 42 -58 % of the human milk samples contained more than 10 ng/l. Our findings suggest that OA contamination may be a potential health problem. Infants are generally more susceptible to exposures to environmental toxins than adults, and may be more vulnerable to their effects. Shortterm adverse effects from OA have not been documented in humans at the 9 concentrations known to be present in human milk. However, because of the continuous intake and the long elimination half-life (35 days in adult humans) (19) the infant may build up high concentrations of the toxin over time. Risk assessments that have been carried out for OA do not differentiate between risk to children and risk to adults. Further investigations are needed regarding the potential long-term health effects of OA intake in the contamination range found in this work.
The prevalence of OA contamination in east-and middle-part of Norway was approximately the same as reported in the Swedish study (9) , but the mean values were higher in the Norwegian samples. The prevalence of OA in human milk in Sweden and in Norway is higher than reported from Switzerland (16) and Germany (15) . The results may indicate that the average exposure to OA of the population in some regions of Norway is higher than in Sweden, Germany and Switzerland.
The geographical variations in the level of OA contamination of the milk seen in this study may be due to differences in dietary habits, and may also be due to regional differences in inhalation exposure to fungal spores. In the northern part of Norway there was a significant lower incidence and level of OA contamination of the milk.
There are minor farming activities (grain processing, hay handling etc.) in the northern areas, which might reduce the exposure to airborne fungal spores. To evaluate the regional differences in OA levels in human milk found in this study, more data is needed regarding consumption data and OA levels in foodstuffs in
Norway.
